Predictors of infusion reactions during infliximab treatment in patients with arthritis.
about
74-week follow-up of safety of infliximab in patients with refractory rheumatoid arthritis.Fcγ receptor IIIb polymorphism and use of glucocorticoids at baseline are associated with infusion reactions to infliximab in patients with rheumatoid arthritis.Infliximab in the treatment of plaque type psoriasis.Adverse events of anti-tumor necrosis factor α therapy in ankylosing spondylitisCombination therapy for the treatment of Crohn's disease.Correlation of antinuclear antibody and anti-double-stranded DNA antibody with clinical response to infliximab in patients with rheumatoid arthritis: a retrospective clinical study.Biological therapies for the treatment of juvenile idiopathic arthritis: Lessons from the adult and pediatric experiences.Infliximab in the treatment of rheumatoid arthritisInfliximab for the treatment of psoriasis in the U.K.: 9 years' experience of infusion reactions at a single centre.Assessing immunogenicity of biosimilar therapeutic monoclonal antibodies: regulatory and bioanalytical considerations.Including adverse drug events in economic evaluations of anti-tumour necrosis factor-α drugs for adult rheumatoid arthritis: a systematic review of economic decision analytic models.Biologic monotherapy in the treatment of rheumatoid arthritis.Skin Signs of Rheumatoid Arthritis and its Therapy-Induced Cutaneous Side Effects.Pulmonary implications in inflammatory bowel disease: not a rare event.Safety and tolerability of infliximab therapy: suggestions and criticisms based on wide clinical experience.Synthesis and biological evaluation of imidazo[1,2-[Formula: see text]]pyridazines as inhibitors of TNF-[Formula: see text] production.Autoantibodies Associated With Connective Tissue Diseases: What Meaning for Clinicians?
P2860
Q34027648-D12B83CA-9CB9-414A-BFB3-98A5DA81607AQ34462584-19C172F6-E57B-4DC0-9176-4ED19E1909D0Q34620291-6FFC2A92-4797-4E3D-B861-1CAA71B22129Q35170882-59A8F931-64D0-4BE7-9EC2-01A3C412F428Q35714202-DDCF5766-B9CB-4DC0-B09A-674B2B986CA4Q35907845-613754D8-3368-4F3F-A6B1-3417672B5A81Q37290665-44946963-CAE7-484F-B42A-0DB99268C4FFQ37303230-256F6498-8F03-431A-9482-527D6F687E68Q37992139-8951D577-245F-4AA4-83B8-410C2583E55BQ38083093-B28C7A9D-FFCD-4ADD-8A1A-8CD388663E79Q38171360-0DA10183-FC7A-4E06-919D-D25F6EEABCF1Q38510023-7A36554E-A29E-4E32-9281-C3A06AC378CDQ38663608-EB9F3AE0-0B38-4A8D-95FD-D10781102068Q40750800-C68AC0C6-0445-40C6-96A6-58B5A10D25F1Q46545377-10AF6583-8206-4E44-BC85-AE582C05BC9FQ48500215-C2908C69-639D-4470-BCBF-D9DBB8603BFAQ52597638-F4DF1D58-5753-48AB-B26D-E17947BFAAA6
P2860
Predictors of infusion reactions during infliximab treatment in patients with arthritis.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
Predictors of infusion reactions during infliximab treatment in patients with arthritis.
@ast
Predictors of infusion reactions during infliximab treatment in patients with arthritis.
@en
type
label
Predictors of infusion reactions during infliximab treatment in patients with arthritis.
@ast
Predictors of infusion reactions during infliximab treatment in patients with arthritis.
@en
prefLabel
Predictors of infusion reactions during infliximab treatment in patients with arthritis.
@ast
Predictors of infusion reactions during infliximab treatment in patients with arthritis.
@en
P2093
P2860
P356
P1476
Predictors of infusion reactions during infliximab treatment in patients with arthritis.
@en
P2093
Gunnar Sturfelt
Lennart Truedsson
Lotta Larsson
Meliha C Kapetanovic
Pierre Geborek
Tore Saxne
P2860
P2888
P356
10.1186/AR2020
P577
2006-01-01T00:00:00Z
P5875
P6179
1051729755